AstraZeneca and Chi-Med’s Savolitinib Shows Encouraging Clinical Activ
Data for savolitinib in combination with Tagrisso or Iressa presented at Wor...
2017-10-17
文传商讯
Results from Phase 2 Studies of Oral Ozanimod in Crohn’s Disease and U
In the STEPSTONE open-label study, ozanimod demonstrated meaningful clinical...
2017-10-17
文传商讯
CHMP positive opinion to include RE-CIRCUIT data for atrial fibrillatio
The CHMP of the EMA has issued a positive opinion for an update of the Summa...
2017-09-21
文传商讯
IPF World Week 2017: Boehringer Ingelheim helps healthcare professional
• Even though progress has been made, diagnosis of idiopathic pulmonary...
2017-09-19
文传商讯
Safety and efficacy results from the INJOURNEYTM trial investigating OF
Data from this 12-week study show that the safety and tolerability profile o...
2017-09-12
文传商讯
Janssen Announces Phase 3 Pivotal Study Results for Darunavir-Based Com
- Interim results from the pivotal EMERALD trial presented during an oral se...
2017-07-26
文传商讯
People with idiopathic pulmonary fibrosis (IPF) reveal high burden of d
61% of IPF patients are worried or extremely worried about experiencing an a...
2017-07-25
文传商讯
Final Phase III Study Results Confirm Benefit of Praxbind® as Rever
Complete data set from 503 patients show that Praxbind (idarucizumab) led to...
2017-07-12
文传商讯
New data reveal high rates of stroke history in asymptomatic atrial fib
Findings from global observational study, GLORIA-AF, reinforce the high need...
2017-06-22
文传商讯
Takeda and Seattle Genetics Announce Lancet Publication of Phase 3 ALCA
CAMBRIDGE, Mass. & OSAKA, Japan & BOTHELL, Wash.--(BUSINESS WIRE)--Takeda Ph...
2017-06-14
文传商讯
